Palatin Technologies (PTN) Market Capitalization (2010 - 2026)
Palatin Technologies' (PTN) quarterly Market Capitalization came in at $68.1 million in Q1 2026, up 345.99% on a YoY basis from $15.3 million in Q1 2025, and up 74.47% quarter-over-quarter from $39.1 million in Q4 2025.
Analysis
Palatin Technologies (PTN) Market Capitalization (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Market Capitalization for 17 consecutive years, with $68.1 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Market Capitalization rose 345.99% year-over-year to $68.1 million; the trailing twelve-month figure through Mar 2026 stood at $68.1 million (up 345.99% YoY), and the FY2025 full-year result was $102.9 million, down 92.82% from the prior year.
- Market Capitalization climbed to $68.1 million in Q1 2026 per PTN's latest filing, from $39.1 million in the prior quarter.
- Across five years, Market Capitalization topped out at $133.3 billion in Q1 2022 and bottomed at $3.7 million in Q2 2025.
- Historically, Market Capitalization has averaged $20.9 billion across 5 years, with a median of $1.3 billion in 2024.
- The sharpest annual moves came in 2025 and 2026: Market Capitalization plunged 99.74% in 2025, then surged 345.99% in 2026.
- Over 5 years, Market Capitalization stood at $29.7 billion in 2022, then tumbled by 90.4% to $2.8 billion in 2023, then tumbled by 54.27% to $1.3 billion in 2024, then slumped by 97.0% to $39.1 million in 2025, then soared by 74.47% to $68.1 million in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $68.1 million, $39.1 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 68.15 Mn |
| Dec 31, 2025 | 39.06 Mn |
| Sep 30, 2025 | 7.71 Mn |
| Jun 30, 2025 | 3.69 Mn |
| Mar 31, 2025 | 15.28 Mn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 869.89 Mn |
| Jun 30, 2024 | 1.43 Bn |
| Mar 31, 2024 | 1.34 Bn |
| Dec 31, 2023 | 2.85 Bn |
| Sep 30, 2023 | 901.97 Mn |
| Jun 30, 2023 | 1.22 Bn |
| Mar 31, 2023 | 31.87 Bn |
| Dec 31, 2022 | 29.67 Bn |
| Sep 30, 2022 | 68.61 Bn |
| Jun 30, 2022 | 81.12 Bn |
| Mar 31, 2022 | 133.27 Bn |
| Dec 31, 2021 | 147.71 Bn |
| Sep 30, 2021 | 127.22 Bn |
| Jun 30, 2021 | 175.41 Bn |